葛兰素史克(GSK)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GSK 葛兰素史克

交易中 09-04 09:52:57 EDT

49.95

-0.92

-1.81%

最高50.06	最低49.66	成交量33.66万
今开49.70	昨收50.87	日振幅0.79%
总市值1,010亿	流通市值969.03亿	总股本20.23亿
成交额1,679万	换手率0.02%	流通股本19.40亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GSK","market":"US","secType":"STK","nameCN":"葛兰素史克","latestPrice":49.95,"timestamp":1788529968212,"preClose":50.87,"halted":0,"volume":336601,"delay":0,"changeRate":-0.01808531551012374,"floatShares":1939999999,"shares":2022697682,"eps":3.127128,"marketStatus":"交易中","change":-0.92,"latestTime":"09-04 09:52:57 EDT","open":49.7,"high":50.06,"low":49.66,"amount":16794912.22161,"amplitude":0.007863,"askPrice":49.97,"askSize":1000,"bidPrice":49.94,"bidSize":2046,"shortable":3,"etf":0,"ttmEps":3.127128,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1788552000000},"marketStatusCode":2,"adr":1,"adrRate":2,"listingDate":977893200000,"exchange":"NYSE","adjPreClose":50.87,"dividendRate":0.036735,"preHourTrading":{"tag":"盘前","latestPrice":49.73,"preClose":50.87,"latestTime":"09:29 EDT","volume":41755,"amount":2087254.95272,"timestamp":1788528597928,"change":-1.14,"changeRate":-0.02241,"amplitude":0.017496},"postHourTrading":{"tag":"盘后","latestPrice":50.87,"preClose":50.87,"latestTime":"19:30 EDT","volume":32675,"amount":1662175.34,"timestamp":1788478205858,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.970791,"impliedVol":0.2812,"impliedVolPercentile":0.3532},"requestUrl":"/m/hq/s/GSK","defaultTab":"news","newsList":[{"id":"2664960827","title":"总额可达12.95亿美元！和黄全球首创偶联药物出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2664960827","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664960827?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:03","pubTimestamp":1788422625,"startTime":"0","endTime":"0","summary":"9月3日，和黄医药（00013.HK）宣布旗下子公司和记黄埔与葛兰素史克（GSK）附属公司达成独家开发及许可协议，授予后者除中国大陆、香港、澳门和台湾以外的全球范围内开发和商业化HMPL-A830的权利。临床开发将首先聚焦于结直肠癌、胰腺癌和肺癌适应症。协议包括1.1亿美元的首付款以及潜在的开发、注册和商业化里程碑付款，总额可达12.95亿美元，外加基于净销售额的特许权使用费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609033864044420.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609033864044420.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00013","BK1191","BK1588","BK4588","BK1587","LU1829250122.USD","GSK","BK4585","GSK.UK","BK4007","BK4532","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124565155","title":"和黄医药午后飙升逾16%，与葛兰素史克达成最高12.95亿美元肿瘤药授权合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1124565155","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124565155?lang=zh_cn&edition=full","pubTime":"2026-09-03 15:56","pubTimestamp":1788422188,"startTime":"0","endTime":"0","summary":"$和黄医药(00013)$周四午后股价大幅走高，一度升逾16%，势创2022年11月以来最大单日升幅。消息面上，和黄医药周四宣布，旗下公司与$葛兰素史克(GSK)$附属公司签署独家开发及许可协议，双方将合作开发及商业化在研肿瘤药物HMPL-A830。根据协议，和黄医药将获得1.1亿美元首付款，并有权获得最高12.95亿美元的开发、监管及商业化里程碑付款，以及产品上市后的净销售额特许权使用费。受大额授权合作消息刺激，和黄医药午后获资金明显追捧，股价升幅迅速扩大。","market":"hk","thumbnail":"https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/25bb080e73b6be662c435ea6aeaec9c7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00013","GSK","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662081157","title":"葛兰素史克(GSK)拟发行至少20亿欧元债券，以偿还并购融资贷款。","url":"https://stock-news.laohu8.com/highlight/detail?id=2662081157","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662081157?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:00","pubTimestamp":1787824828,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["FYLG","LQPE","MNA","TFNS","NBIE","FXE","BK4585","BK4588","MRGR","GSKH","ARB","LU1829250122.USD","RSPF","PEX","GSK","BK4007","GSK.UK","BUYO","BK4532","LBO","BNDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181045381","title":"异动解读｜葛兰素史克盘中上涨3.01%，制药板块集体走强叠加多重利好催化","url":"https://stock-news.laohu8.com/highlight/detail?id=1181045381","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181045381?lang=zh_cn&edition=full","pubTime":"2026-08-20 03:09","pubTimestamp":1787166556,"startTime":"0","endTime":"0","summary":"8月20日，葛兰素史克盘中上涨3.01%，报52.685美元/股，成交额1.42亿美元。消息面上，制药板块当日集体走强，同业默沙东大涨13.16%、礼来涨4.82%、辉瑞涨3.89%，板块资金流入明显。公司层面，近日利好密集释放：8月18日，中外制药与GSK签署抗登革热病毒抗体AID351独家许可协议，GSK获得该药物全球独家开发、生产和商业化权利；同日，核心产品NUCALA获加拿大药品管理局积极报销推荐，适应症拓展至成人慢性阻塞性肺疾病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660493380","title":"GSK：NUCALA获加拿大药品管理局积极报销推荐，用于成人慢性阻塞性肺疾病治疗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2660493380","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660493380?lang=zh_cn&edition=full","pubTime":"2026-08-18 22:23","pubTimestamp":1787062997,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1829250122.USD","GSK","BK4585","GSKH","BK4588","BK4532","GSK.UK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456776","title":"中外制药与葛兰素史克签署抗登革热病毒抗体“AID351”独家许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456776","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660456776?lang=zh_cn&edition=full","pubTime":"2026-08-18 10:49","pubTimestamp":1787021377,"startTime":"0","endTime":"0","summary":"【中外制药与葛兰素史克签署抗登革热病毒抗体“AID351”独家许可协议】据中外制药官网消息，8月18日，中外制药宣布已与葛兰素史克签署独家许可协议，葛兰素史克将获得抗登革热病毒抗体药物“AID351”的全球独家开发、生产和商业化权利，并负责该药物的临床开发及生产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608183844335660.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608183844335660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4532","BK1574","BK4007","BK4585","GSK.UK","GSK","01477","BK1191","GSKH","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456160","title":"中外制药与葛兰素史克达成协议，共同推进登革热抗体药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456160","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660456160?lang=zh_cn&edition=full","pubTime":"2026-08-18 10:38","pubTimestamp":1787020681,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","BK4585","BK4007","GSK.UK","GSK","GSKH","LU1829250122.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659945158","title":"葛兰素史克：董事会批准根据公司净资产，按资产市场价值分配公司合并后股本。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659945158","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659945158?lang=zh_cn&edition=full","pubTime":"2026-08-13 17:58","pubTimestamp":1786615104,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1829250122.USD","GSKH","BK4585","GSK.UK","BK4007","BK4588","BK4532","GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655336136","title":"GSK上半年核心营业利润增长 管线优化同步推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2655336136","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655336136?lang=zh_cn&edition=full","pubTime":"2026-07-31 21:00","pubTimestamp":1785502815,"startTime":"0","endTime":"0","summary":"7月28日，葛兰素史克（GSK）公布2026年第二季度及上半年业绩。财报显示，今年上半年，葛兰素史克实现总营收160.38亿英镑，同比增长5%（以固定汇率计价，下同）；受期内药物临床试验失败等因素影响，公司总营业利润为27.74亿英镑，同比减少31%。不过，公司核心营业利润（剔除非经常性项目后的“常态化”利润）为54.50亿英镑，同比增长8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607313828578150.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607313828578150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4585","BK4007","BK4588","GSK","GSKH","LU1829250122.USD","BK4532","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654888584","title":"美股异动 | 医药板块走强 葛兰素史克(GSK.US)绩后大涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654888584","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654888584?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:50","pubTimestamp":1785250222,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GSKH","BK4007","GSK","BK4588","LU1829250122.USD","GSK.UK","BK4585","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117275596","title":"美股异动｜医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117275596","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117275596?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:29","pubTimestamp":1785248946,"startTime":"0","endTime":"0","summary":"7月28日，医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%，强生涨近3%，礼来涨超2%。消息面上，葛兰素史克公布的二季度财报显示，调整后每股收益为50.5便士，显著高于市场预期的46.8便士，盈利表现超出预期。与此同时，葛兰素史克宣布计划到2029年全面实现每年19亿英镑的成本节约，这一目标进一步增强了投资者对公司未来盈利能力的信心。","market":"us","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","GSKH","GSK","JNJ","LLII","LLYX","ELIS","ABBV","PFE","LLYZ","MRK","ELIL","LLY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1184563045","title":"异动解读 | 葛兰素史克盘中大涨5.31%，第二季度盈利超预期及成本节约计划提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1184563045","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184563045?lang=zh_cn&edition=full","pubTime":"2026-07-28 21:39","pubTimestamp":1785245973,"startTime":"0","endTime":"0","summary":"葛兰素史克(GSK)今日盘中股价大幅上涨5.31%，引发市场广泛关注。消息面上，公司在盘前公布的2026年第二季度业绩报告显示，调整后每股收益为50.5便士，明显高于市场预估的46.8便士，盈利表现超出预期。此外，公司宣布计划到2029年全面实现每年19亿英镑的成本节约，并宣布未来三年内在英国投资4亿英镑，于剑桥生物医学园区建立新旗舰研发中心，以加速肿瘤学、疫苗等核心领域的研发管线推进。公司首席执行官还表示，现有营收与收益流规模足以抵消艾滋病药物专利失效带来的损失，进一步增强了投资者信心。强劲的业绩表现、明确的成本优化目标以及研发领域的战略投资，共同推动了葛兰素史克今日盘中的显著上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155097503","title":"异动解读｜葛兰素史克盘中上涨4.44%，Q2营收及盈利双双超预期叠加成本节约目标提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1155097503","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1155097503?lang=zh_cn&edition=full","pubTime":"2026-07-28 21:34","pubTimestamp":1785245687,"startTime":"0","endTime":"0","summary":"7月28日，葛兰素史克盘中上涨4.44%，报54.67美元/股，成交额4353.41万美元。消息面上，公司当日公布二季度财报，调整后每股收益1.35美元，超出市场预期的1.27美元，同比增长8.87%；营收112.8亿美元，高于预期的107.9亿美元。公司同时宣布目标在2029年前全面实现每年19亿英镑的成本节约，并表示现有营收与收益流规模足以抵消艾滋病药物专利失效带来的损失。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134607161","title":"美股开盘 | 三大指数涨跌不一，康宁跌超14%，葛兰素史克涨超4%，可口可乐涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134607161","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134607161?lang=zh_cn&edition=full","pubTime":"2026-07-28 21:31","pubTimestamp":1785245499,"startTime":"0","endTime":"0","summary":"7月28日，美股三大指数开盘涨跌不一，道指涨0.66%，纳指跌0.61%，标普500跌0.14%。康宁跌超14%，Q2营收利润双超预期，但Q3收入指引不够“惊喜”；葛兰素史克涨超4%，可口可乐涨超3%，波音、PayPal涨近1%。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UUP","SPXS","CNAV","SPXL",".IXIC","UDOW","DMAX","DOG","IVV","SPXU","BA","GLWG","PYPG","DXD",".SPX","SPYH","LU2290526834.HKD","PYPY","KO","GSK","LU0963586101.USD","SPYU","GSKH","SPY",".DJI","SH","DRAM","SPYQ","LU1861215975.USD","MMAX","LU2360107168.USD","BOEG","LU1861220033.SGD","PTF","SPUU","BOEU","GLW","RAM","SSO","BK4588","VOO","DDM","PYPL","SPDN","SDOW","SDS","SMAX","UPRO","HIBL","DIA","LU0054578231.USD","BOED","UDN","BK4170","YSPY","SPYM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654001756","title":"葛兰素史克首席执行官：媒体电话会议发言称，我们认为公司现有营收与收益流规模充足，足以抵消艾滋病药物专利失效带来的损失。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654001756","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654001756?lang=zh_cn&edition=full","pubTime":"2026-07-28 20:03","pubTimestamp":1785240196,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GSKH","GSK.UK","BK4585","BK4532","GSK","LU1829250122.USD","BK4588","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173928579","title":"葛兰素史克盘前涨超3%，Q2盈利表现超预期并加码肿瘤研发布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1173928579","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173928579?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:42","pubTimestamp":1785238956,"startTime":"0","endTime":"0","summary":"葛兰素史克今日盘前股价涨超3%，报53.67美元。消息面上，公司公布的二季度财报显示，调整后每股收益为50.5便士，显著高于市场预期的46.8便士，盈利表现超出预期。与此同时，葛兰素史克宣布计划到2029年全面实现每年19亿英镑的成本节约，这一目标进一步增强了投资者对公司未来盈利能力的信心。此外，公司近期在肿瘤管线方面取得进展，完成了对Nuvalent的收购，并推进了乙肝功能性治愈药物等研发项目，这些积极因素也为股价上涨提供了支撑。","market":"us","thumbnail":"https://community-static.tradeup.com/news/cd4dce981f312a5c85cfc3c3dedcb311","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/cd4dce981f312a5c85cfc3c3dedcb311"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654009999","title":"葛兰素史克拟在英国剑桥生物医学园区建立新旗舰研发中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2654009999","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654009999?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:26","pubTimestamp":1785238009,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","BK4588","BK4007","LU1829250122.USD","GSK.UK","GSK","GSKH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654695009","title":"葛兰素史克美股盘前涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654695009","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654695009?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:23","pubTimestamp":1785237809,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","GSK","BK4532","BK4588","GSKH","BK4007","GSK.UK","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654300952","title":"葛兰素史克：未来三年内向英国投资4亿英镑","url":"https://stock-news.laohu8.com/highlight/detail?id=2654300952","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654300952?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:21","pubTimestamp":1785237674,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4532","LU1829250122.USD","GSK.UK","BK4588","GSK","BK4585","GSKH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143220684","title":"异动解读｜葛兰素史克盘前上涨3.52%，Q2盈利超预期叠加成本节约目标提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1143220684","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143220684?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:17","pubTimestamp":1785237420,"startTime":"0","endTime":"0","summary":"7月28日，葛兰素史克盘前上涨3.52%，报53.86美元/股，成交额309.32万美元。消息面上，公司当日公布二季度财报，调整后每股收益为50.5便士，超出市场预期。此外，公司表示目标在2029年前全面实现每年19亿英镑的成本节约，进一步提振投资者信心。此前市场对公司盈利预期曾多次下调，实际业绩超预期形成正向预期差。公司肿瘤业务增速位居各板块之首，一季度同比增长28%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gsk.com","stockEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":-0.0128},{"period":"3month","weight":-0.0126},{"period":"6month","weight":-0.0668},{"period":"1year","weight":0.2924},{"period":"ytd","weight":0.0373}],"compareEarnings":[{"period":"1week","weight":0.0027},{"period":"1month","weight":0.0024},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1499},{"period":"1year","weight":0.2011},{"period":"ytd","weight":0.1338}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"GSK Plc于1999年12月6日在英国成立的公众服务有限公司，是一个世界领先的研究型制药和保健公司，由Glaxo Wellcome plc和SmithKline Beecham plc合并而成。公司致力于开发较现有治疗方案明显改善的新产品，为病人和政府、保险公司或其他第三方提供帮助。","yearOnYearQuotes":[{"month":1,"riseRate":0.586957,"avgChangeRate":0.013809},{"month":2,"riseRate":0.478261,"avgChangeRate":0.001243},{"month":3,"riseRate":0.608696,"avgChangeRate":0.019112},{"month":4,"riseRate":0.659574,"avgChangeRate":0.030828},{"month":5,"riseRate":0.404255,"avgChangeRate":-0.008644},{"month":6,"riseRate":0.595745,"avgChangeRate":0.010234},{"month":7,"riseRate":0.531915,"avgChangeRate":0.003565},{"month":8,"riseRate":0.574468,"avgChangeRate":0.00509},{"month":9,"riseRate":0.531915,"avgChangeRate":0.006108},{"month":10,"riseRate":0.521739,"avgChangeRate":0.013062},{"month":11,"riseRate":0.478261,"avgChangeRate":0.009917},{"month":12,"riseRate":0.608696,"avgChangeRate":0.014188}],"exchange":"NYSE","name":"葛兰素史克","nameEN":"GlaxoSmithKline PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"葛兰素史克(GSK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供葛兰素史克(GSK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"葛兰素史克,GSK,葛兰素史克股票,葛兰素史克股票老虎,葛兰素史克股票老虎国际,葛兰素史克行情,葛兰素史克股票行情,葛兰素史克股价,葛兰素史克股市,葛兰素史克股票价格,葛兰素史克股票交易,葛兰素史克股票购买,葛兰素史克股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"葛兰素史克(GSK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供葛兰素史克(GSK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}